AdaptHealth Corp. (AHCO)

In the past six months, AdaptHealth's stock experienced several notable events. The company announced its third-quarter 2025 results, reporting a net revenue increase and organic revenue growth, and reduced debt. AdaptHealth received credit upgrades from S&P and Moody's rating agencies. The company announced its fourth-quarter and full-year 2025 results, with a decrease in net revenue but positive organic revenue growth; however, they reported a significant GAAP net loss due to a non-cash goodwill impairment charge, which led to a stock decline. The company continued its debt reduction efforts. Over the past month, the stock has increased, and year-to-date, it has seen a return.

The demand for AdaptHealth's products and services is generally stable throughout the year due to its focus on providing home healthcare equipment and medical supplies for chronic conditions. The company's consistent achievement of patient census records and retention records across its segments supports the notion of a steady demand.

AdaptHealth Corp. is a national provider of patient-centered, healthcare-at-home solutions in the United States, operating in the Healthcare sector and Medical Devices industry. The company provides home medical equipment (HME), medical supplies, and related services. Their services include sleep therapy equipment for obstructive sleep apnea, oxygen and ventilation equipment for respiratory diseases, medical devices for diabetes management, and general home medical equipment and services for patients discharged from acute care facilities, including supplies for wound care, urological, incontinence, ostomy, and nutritional needs.

AdaptHealth has an extensive geographic reach across the United States, operating in all 50 states. The company maintains a network of approximately 644 to over 700 locations in 47 to 48 states, serving millions of patients annually.

AdaptHealth's brand reputation has been influenced by both positive strategic developments and financial performance. A significant positive event was the agreement to become the capitated provider of durable home medical equipment and supplies to Humana Medicare Advantage HMO members. The company reported setting patient census records for Sleep Health, Respiratory Health, and Wellness at Home, and a patient retention record for Diabetes Health. The reported GAAP net loss and a non-cash goodwill impairment charge in Q4 2025 could have a short-term negative impact on reputation among some investors.

AdaptHealth Corp. has significant institutional ownership. Major institutional owners include BlackRock, Inc., OEP Capital Advisors, L.P., Vanguard Group Inc, Deerfield Management Company, L.P. (series C), and SkyKnight Capital, L.P. Insiders, including Everest Hill Group Inc. and Richard M. Cashin Jr., also hold substantial stakes. In the past three months, insiders have purchased a net of over $24 million in company stock.